Locoregional therapies in cholangiocarcinoma

Hepatic Oncology · Published 2017-10-01 · DOI 10.2217/hep-2017-0014

Authors being retrieved — see the publisher record. https://doi.org/10.2217/hep-2017-0014

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2017

Related articles

• Comparison of long-term clinical outcomes between radiofrequency ablation and hepatic resection in patients with small (≤2 cm) hepatocellular carcinoma · Hepatic Oncology · 2024 · Same journal
• Uncooled TATO Microwave System for Liver Ablation · Hepatic Oncology · 2022 · Same journal
• Cytoplasmic translocation of nuclear LSD1 ( KDM1A ) in human hepatoma cells is induced by its inhibitors · Hepatic Oncology · 2019 · Same journal
• Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery · Hepatic Oncology · 2020 · Same journal
• Selective internal radiation therapy: an effective treatment for hormonal syndromes in pancreatic neuroendocrine tumors · Hepatic Oncology · 2018 · Same journal
• Is hepatocellular carcinoma surveillance in high-risk populations effective? · Hepatic Oncology · 2020 · Same journal
• Impact of β-blockers on Survival Outcomes in Patients with Unresectable Hepatocellular Carcinoma · Hepatic Oncology · 2022 · Same journal
• Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy · Hepatic Oncology · 2025 · Same journal
• Advances in liver transplantation for hepatic malignancies · Hepatic Oncology · 2026 · Same journal
• Pathological complete Response with Immunotherapy and Brachytherapy to 15 Metastatic Liver Lesions in a Single Patient · Hepatic Oncology · 2022 · Same journal